Laborie Medical Technologies

Laborie Medical Technologies is a global developer and manufacturer of innovative medical technology and consumables focused on diagnosing and treating urinary and fecal incontinence, as well as other pelvic floor disorders. The company serves the urology, gynecology, and colorectal fields, providing specialized diagnostic and therapeutic equipment. Laborie is known for its advanced urodynamic testing solutions that help identify the underlying causes of urinary incontinence, thereby facilitating effective treatment options for patients. The company's products aim to improve patient outcomes and enhance the quality of care in healthcare settings.

Nikki Bruce

Vice President, Global OB Business Segment

Michael Frazzette

President and CEO

19 past transactions

Bright Uro

Series A in 2024
Bright Uro is an early-stage medical technology company focused on developing innovative diagnostic devices specifically for urology. The company is creating a cutting-edge urodynamics system that integrates advanced hardware, software, and data science to deliver wireless, catheter-free urodynamics. This approach aims to enhance accuracy and comfort in the diagnosis and treatment of lower urinary tract symptoms and diseases. By providing clinicians with actionable insights, Bright Uro seeks to fundamentally improve patient outcomes and transform the standard of care in urology.

Vensica

Venture Round in 2024
Vensica is a medical technology company focused on developing an innovative ultrasound-based drug delivery system for the treatment of urinary bladder conditions, particularly overactive bladder (OAB) and bladder cancer. The company's approach seeks to overcome the limitations of traditional drug administration methods, which involve catheter insertion and are often painful and ineffective. By utilizing ultrasound technology, Vensica's system allows for a needle-free, quick, and pain-free drug instillation procedure. The application of ultrasound enhances drug uptake and penetration into the bladder wall, aiming to improve treatment efficacy and reduce the high recurrence rates commonly associated with urinary bladder cancer. This method represents a significant advancement in therapeutic approaches, enabling healthcare providers to offer safer and more effective treatment options for patients.

I-O Urology

Venture Round in 2024
I-O Urology specializes in developing and providing a patient monitoring system tailored for urology. Their technology enables real-time tracking of patient symptoms at home, enhancing data accuracy, facilitating timely and appropriate diagnoses, improving patient satisfaction and comfort, and ultimately reducing overall healthcare costs.

Bright Uro

Series A in 2023
Bright Uro is an early-stage medical technology company focused on developing innovative diagnostic devices specifically for urology. The company is creating a cutting-edge urodynamics system that integrates advanced hardware, software, and data science to deliver wireless, catheter-free urodynamics. This approach aims to enhance accuracy and comfort in the diagnosis and treatment of lower urinary tract symptoms and diseases. By providing clinicians with actionable insights, Bright Uro seeks to fundamentally improve patient outcomes and transform the standard of care in urology.

Urotronic

Acquisition in 2023
Urotronic Inc., established in 2014 and headquartered in Plymouth, Minnesota, specializes in developing and manufacturing medical devices for urological applications. The company's primary product is Optilume, a Drug Coated Balloon (DCB) catheter designed to treat urethral strictures in men by dilating the blocked area and delivering a drug that prevents scar tissue formation. This minimally invasive procedure reduces patient discomfort and recovery time compared to traditional surgical methods. Urotronic serves both urologists and patients, aiming to improve treatment outcomes for urinary tract conditions.

GIE Medical

Corporate Round in 2023
GIE Medical is a medical technology company focused on developing innovative solutions for gastroenterological conditions. It specializes in the creation of drug-coated balloon technology designed to treat benign strictures in the esophagus, small intestine, colon, and rectum. The company's investigational device aims to improve patient outcomes by maintaining long-term patency and reducing the need for repeated treatments.

Novonate

Acquisition in 2023
Novonate is a healthcare technology company focused on improving neonatal care through innovative medical devices. Their flagship product, LifeBubble, is designed to enhance vascular catheter protection and securement in intensive care settings. By providing stronger umbilical catheter securement, LifeBubble helps reduce the risk of complications such as catheter migration and premature discontinuation, thereby enhancing the safety and stability of neonatal treatments.

GI Supply

Acquisition in 2022
GI Supply, Inc. is a manufacturer based in Mechanicsburg, Pennsylvania, specializing in innovative endoscopy and paracentesis products tailored for gastroenterologists, colorectal surgeons, and interventional radiologists. Founded nearly 30 years ago by Dr. Frank Jackson, the company aims to address clinical challenges encountered in daily practice. Its product lineup includes endoscopic tattoos, submucosal lifting agents, endoscopic injection needles, endoscope transport bags, bite blocs, and paracentesis management systems. GI Supply's offerings enhance physician efficiency and improve patient satisfaction, with its products currently utilized daily by medical professionals in over 40 countries worldwide.

Vensica

Venture Round in 2021
Vensica is a medical technology company focused on developing an innovative ultrasound-based drug delivery system for the treatment of urinary bladder conditions, particularly overactive bladder (OAB) and bladder cancer. The company's approach seeks to overcome the limitations of traditional drug administration methods, which involve catheter insertion and are often painful and ineffective. By utilizing ultrasound technology, Vensica's system allows for a needle-free, quick, and pain-free drug instillation procedure. The application of ultrasound enhances drug uptake and penetration into the bladder wall, aiming to improve treatment efficacy and reduce the high recurrence rates commonly associated with urinary bladder cancer. This method represents a significant advancement in therapeutic approaches, enabling healthcare providers to offer safer and more effective treatment options for patients.

Pelvalon

Acquisition in 2021
Pelvalon is a medical device company focused on improving the quality of life for women experiencing fecal incontinence. The company develops innovative, non-surgical therapy devices aimed at addressing the challenges associated with pelvic and bowel health. By providing a treatment option that does not involve drugs or hormones, Pelvalon offers a solution for women suffering from accidental bowel leakage, helping them regain bowel control and enhance their overall well-being.

Clinical Innovations

Acquisition in 2019
Clinical Innovations is the largest healthcare manufacturer exclusively focused on labor and delivery. Already a market leader in several categories with products such as the Koala® Intrauterine Pressure Catheter and Kiwi® Vacuum-Assisted Delivery System, Clinical Innovations is expanding its global presence while directly researching and developing state-of-the-art technologies and innovative medical devices that fulfill its mission of improving the lives of mothers and their babies throughout the world. Since its inception in 1993, Clinical Innovations has consistently expanded its worldwide presence, becoming the market leader in several product categories. This growth has fueled the ability to invest in new product ideas where innovation makes the difference. And with a management team with extensive experience in the medical device industry, Clinical Innovations possesses the working knowledge to develop those new product ideas into industry-changing specialty devices. Clinical Innovations is dedicated to quality and customer service. With ISO13485 certification and strong relationships with top worldwide medical distributors, Clinical Innovations has the systems and infrastructure in place to promptly respond to market trends and customer suggestions. Clinical Innovations is a Prizker Group Company.

Cogentix Medical

Acquisition in 2018
Cogentix Medical, Inc. is a medical device company based in Minnetonka, Minnesota, specializing in the design, development, manufacturing, and marketing of advanced fiberoptic and video endoscopy products under the PrimeSight brand. The company offers a variety of endoscopes, including cystoscopes and bronchoscopes, along with the EndoSheath Protective Barrier, a sterile, single-use microbial barrier for flexible endoscopes. Cogentix Medical is also known for its Urgent PC System, which provides percutaneous tibial nerve stimulation for the treatment of overactive bladder, and Macroplastique, an injectable urethral bulking agent for adult female stress urinary incontinence. In addition to these products, the company distributes wound care products in the Netherlands and the United Kingdom. Cogentix Medical operates through a direct sales force and a network of distributors, having been formed in 2015 through the merger of Uroplasty and Vision-Sciences.

Andromeda

Acquisition in 2017
ANDROMEDA medizin Systeme GmbH was founded in 1994. ANDROMEDA develops and markets modern and high-quality Urodynamic instruments. As a specialist and pioneer, the company is now one of the world's leading manufacturers of urodynamics.

iTind

Funding Round in 2016
iTind is an Israeli medical device company that specializes in improving men's healthcare, particularly for those suffering from benign prostatic hyperplasia (BPH). The company’s flagship product, the iTind device, is a temporarily implanted nitinol device designed to provide long-lasting relief from BPH symptoms through a minimally invasive, non-surgical procedure. The device is inserted in the prostatic urethra for five days, during which it displaces obstructive tissue, effectively reshaping the prostate to deliver lasting therapeutic benefits. iTind is approved for sale in several regions, including the European Union, the UK, Israel, Australia, and Brazil, and has received FDA clearance for use in the USA. Founded in 2007 and based in Or Akiva, Israel, the company was formerly known as Protech Ltd.

Medical Measurement Systems

Acquisition in 2015
Medical Measurement Systems B.V. is a manufacturer and distributor of diagnostic equipment specializing in urodynamic and gastrointestinal testing. Founded in 1988 and headquartered in Enschede, the Netherlands, the company provides a range of diagnostic solutions, including Uroflowmetry, Urodynamics, Ambulatory Urodynamics, Video Urodynamics, and Neuro-Urodynamics, which assess various functions of the urinary tract. Additionally, it offers gastrointestinal diagnostic tools such as Impedance measurement, pH Reflux measurement, and High Resolution Manometry, among others. Medical Measurement Systems also provides tailored education programs for healthcare professionals, including physicians, nurses, and technicians, ensuring effective use of its products. Its equipment is utilized in small hospitals, private clinics, university hospitals, and research centers, reflecting its commitment to enhancing diagnostic capabilities in the medical field. The company operates as a subsidiary of Laborie Medical Technologies, Inc. since 2015.

Unisensor

Acquisition in 2014
Unisensor is a manufacturer specializing in medical-use sensors and catheters. The company focuses on developing and producing a variety of measurement and multipoint catheters, including pressure and pH catheters for gastroenterology, as well as transurethral and anorectal measurement catheters specifically designed for urological applications. Additionally, Unisensor has created the Compartment System Measuring System (CPMS), which is utilized for both the diagnosis and therapy of muscle compartment syndrome. Through its innovative products, Unisensor aims to enhance clinical procedures and improve patient outcomes in relevant medical fields.

BUCK Elektromedizin

Acquisition in 2014
BUCK Elektromedizin is a medical technology company focused on developing and distributing therapy and diagnostic equipment, particularly in the fields of urology, gynecology, neurology, and speech therapy. The company specializes in electrical stimulation systems, home biofeedback devices, and combination systems designed for treating urinary and fecal incontinence, as well as pain therapy. Its product offerings also include urodynamic and anorectal measuring stations, catering to both clinical and rehabilitation applications. BUCK Elektromedizin is committed to advancing the diagnosis and treatment of various medical conditions through innovative technology and high-quality medical supplies.

Mediwatch

Acquisition in 2013
Mediwatch is a manufacturer and distributor specializing in diagnostic and treatment products for urological and gastrointestinal disorders. The company's product range includes urodynamics systems and disposables, bladder scanners, uroflowmeters, pelvic floor biofeedback equipment, anorectal manometry systems, and PSA testing products. Mediwatch focuses on providing innovative solutions to enhance the diagnosis and management of these medical conditions.

UroMed Technology - Pelvic Muscle Rehabilitation Business

Acquisition in 2013
UroMed Technology - Pelvic Muscle Rehabilitation Business is a provider of pelvic muscle rehabilitation services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.